The S130K fibroblast growth factor-1 mutant induces heparin-independent proliferation and is resistant to thrombin degradation in fibrin glue

Journal of Vascular Surgery

Volumn 31, Issue 2, 2000, Pages 382-390

  Shireman, Paula K ^c,d   Xue, Lian ^a   Maddox, Ewa ^e   Burgess, Wilson H ^e   Greisler, Howard P ^a,b  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b HINES VA HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^e AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN GLUE; FIBROBLAST GROWTH FACTOR 1; HEPARIN; LYSINE; SERINE; THROMBIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DEGRADATION; DOG; ENDOTHELIUM CELL; MUTANT; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; SMOOTH MUSCLE FIBER;

EID: 0033982617     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(00)90168-X     Document Type: Article

References (19)

1. Gimenez-Gallego G, Conn G, Hatcher VB, Thomas KA. Human brain-derived acidic and basic fibroblast growth factors, amino terminal sequences and specific mitogenic activities. Biochem Biophys Res Comm 1986;135:541-8.
2. Thomas KA, Rios-Candelore M, Gimenez-Gallego G, DiSalvo J, Bennett C, Rodkey J, et al. Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1. Proc Natl Acad Sci U S A 1985;82:6409-13.
3. Thomas KA, Rios-Candelore M, Fitzpatrick S. Purification and characterization of acidic fibroblast growth factor from bovine brain. Proc Natl Acad Sci U S A 1984;81:357-61.
4. Schreiber AB, Kenney J, Kowalski J, Thomas KA, Gimenez-Gallego G, Rios-Candelore M, et al. A unique family of endothelial cell polypeptide mitogens: the antigenic and receptor cross-reactivity of bovine endothelial cell growth factor, brain-derived acidic fibroblast growth factor, and eyederived growth factor-II. J Cell Biol 1985;101:1623-6.
5. Schlessinger J. Signal transduction by allosteric receptor oligomerization. Trends Biochem Sci 1988;13:443-7.
6. DiGabriele AD, Lax I, Chen DI, Svahn CM, Jaye M, Schlessinger J, et al. Structure of a heparin-linked biologically active dimer of fibroblast growth factor. Nature 1998;393: 812-7.
7. Gray JL, Kang SS, Zenni GC, Kim DU, Kim PI, Burgess WH, et al. FGF-1 affixation stimulates ePTFE endothelialization without intimai hyperplasia. J Surg Res 1994;57:596-612.
8. Greisler HP, Cziperle DJ, Kim DU, Garfield JD, Petsikas D, Murchan PM, et al. Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor type 1 pretreatment. Surgery 1992;112:244-55.
9. Wong P, Hampton B, Szylobryt E, Gallagher AM, Jaye M, Burgess WH. Analysis of putative heparin-binding domains of FGF-1 using site-directed mutagenesis and peptide analogues. J Biol Chem 1995;70:25805-11.
10. Zarge JI, Huang P, Husak V, Kim DU, Haudenschild CC, Nord RM, et al. Fibrin glue containing fibroblast growth factor type-1 and heparin with autologous endothelial cells reduces intimai hyperplasia in a canine carotid artery balloon injury model. J Vasc Surg 1997;25:840-9.
11. Kang SS, Gosselin C, Ren D, Greisler HP. Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by plus heparin delivered from fibrin glue suspensions. Surgery 1995;118:280-7.
12. Shireman PK, Hampton B, Burgess WH, Greisler HP. Modulation of vascular cell growth kinetics by local cytokine delivery from fibrin glue. J Vasc Surg 1999;29:852-61.
13. Hedlin U, Daum G, Clowes AW. Heparin inhibits thrombin-induced mitogen-activated protein kinase signaling in arterial smooth muscle cells. J Vasc Surg 1998;27:512-20.
14. Burgess WH, Shaheen AM, Ravera M, Jaye M, Donohue PJ, Winkles JA. Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue. J Cell Biol 1990;111:2129-38.
15. Burgess WH, Shaheen AM, Hampton B, Donohue PJ, Winkles JA. Structure-function studies of heparin-binding (acidic fibroblast) growth factor-1 using site-directed mutagenesis. J Cell Biochem 1991;45:131-8.
16. Burgess WH, Friesel R, Winkles JA. Structure-function studies of FGF-1: dissociation and partial reconstitution of certain of its biological activities. Mol Reprod Dev 1994;39:5660.
17. Ortega S, Schaeffer MT, Soderman D, DiSalvo J, Linemeyer DL, Gimenez-Gallego G, et al. Conversion of cysteine to serine residues alters the activity, stability, and heparin dependence of acidic fibroblast growth factor. J Biol Chem 1991;266:5842-6.
18. Weatherford DA, Sackman JE, Reddick TT, Freeman MB, Stevens SL, Goldman MJH. Vascular endothelial growth factor and heparin in a biologic glue promotes human aortic endothelial cell proliferation with aortic smooth muscle cell inhibition. Surgery 1996;120:433-90.
19. Kang SS, Ren D, Gosselin C, Greisler HP. Smooth muscle cell inhibition with endothelial cell stimulation by growth regulators within a fibrin glue delivery vehicle. Surg Forum 1994;45:355-8.